High dose intravenous immunoglobin for systemic lupus erythematosus with lupus nephritis and associated studies - case report
Journal of University of Malaya Medical Centre
; : 51-56, 2007.
Artigo
em Inglês
| WPRIM (Pacífico Ocidental)
| ID: wpr-627703
Biblioteca responsável:
WPRO
ABSTRACT
Systemic lupus erythematosus (SLE) is one of the commonest systemic autoimmune diseases that can present with variable clinical manifestations. Intravenous Immunoglobulin (IVIG) has been used as a salvage therapy for severe lupus with encouraging results though there is yet randomised trial to support the usage. This report highlights the efficacy and safety of high dose IVIG in SLE patients with multi-organ involvement particularly lupus nephritis. We also reviewed the literature on the usage of IVIG for lupus nephritis. However, more studies are needed to further clarify the optimal therapeutic dosage and regime for IVIG and to identify the group of patients who might benefit the most from this expensive therapy.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Ensaio clínico controlado
/
Estudo prognóstico
Idioma:
Inglês
Revista:
Journal of University of Malaya Medical Centre
Ano de publicação:
2007
Tipo de documento:
Artigo